Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
5.59
-0.10 (-1.76%)
Nov 12, 2025, 10:58 AM EST - Market open
Aquestive Therapeutics Market Cap
Aquestive Therapeutics has a market cap or net worth of $682 million as of November 12, 2025. Its market cap has increased by 36.42% in one year.
Market Cap
682.00M
Enterprise Value
606.51M
1-Year Change
36.42%
Ranking
Category
Stock Price
$5.59
Market Cap Chart
Since July 25, 2018, Aquestive Therapeutics's market cap has increased from $393.23M to $682.00M, an increase of 73.44%. That is a compound annual growth rate of 7.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2025 | 694.20M | 113.87% |
| Dec 31, 2024 | 324.59M | 140.67% |
| Dec 29, 2023 | 134.87M | 176.07% |
| Dec 30, 2022 | 48.85M | -68.73% |
| Dec 31, 2021 | 156.24M | -13.14% |
| Dec 31, 2020 | 179.87M | -3.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 885.19B |
| Johnson & Johnson | 466.99B |
| AbbVie | 397.96B |
| UnitedHealth Group | 296.62B |
| AstraZeneca | 275.02B |
| Novartis AG | 249.68B |
| Merck & Co. | 225.74B |
| Abbott Laboratories | 220.84B |